Related Experiment Video
Updated: Aug 8, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Financial toxicity from newly approved second-/third-line agents in metastatic urothelial carcinoma
David J Benjamin1, Mark P Lythgoe2, Arash Rezazadeh3
1Hoag Family Cancer Institute, Newport Beach, CA, USA.
No abstract available in PubMed .
More Related Videos
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Treatment Resistant Cancers
Urinary Tract Calculi III: Medical Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...